北米の乳房再建市場規模、シェア、動向分析レポート：製品別、形状別、最終用途別、地域別、セグメント別予測、2023年～2030年

北米の乳房再建市場の成長と動向：

Grand View Research, Inc.の新しいレポートによると、北米の乳房再建市場規模は、2023年から2030年にかけてCAGR 6.8％で成長し、2030年までに3億6,620万米ドルに達すると予測されています。

これは、この地域内の乳がん患者数の増加に起因しています。例えば、Canadian Cancer Society 2019によると、女性の8人に1人が乳がんと診断される見込みです。さらに、同様の情報源によれば、乳がんはカナダで2番目に多く発生するがんです。したがって、カナダにおける乳がん患者の増加は、北米の乳房再建市場を押し上げると予測されます。

さらに、この地域では乳房再建手術の件数も増加しています。例えば、Archives of Plastic Surgeryによると、乳房切除後の乳房再建手術は2015年の19.4％から2018年には53.4％に増加しています。同様に、カナダがん協会によると、カナダでは女性の5人に1人が乳房切除後の乳房再建を受けています。したがって、乳房再建手術件数の増加が北米の乳房再建市場を牽引すると予想されます。

さらに、さまざまな啓発キャンペーンの開始は、女性の間で意識の高まりにつながっています。例えば、乳房再建啓発キャンペーンは、乳がんの診断後に乳房再建に関する正しい決断をするよう女性を教育し、関与させ、力づけるものです。

北米の乳房再建市場はCOVID-19の影響で落ち込みました。しかし、パンデミック後、市場は大きな成長率を示すと予測されます。COVID-19の間に延期された豊胸手術などの選択的手術は、COVID-19後の期間にも実施されると予想されます。さらに、市場を獲得するために、多くの企業が地理的拡大、製品発売、提携など様々な戦略に参入しています。

例えば、2021年4月、Sientra, Inc.とButterfly Networkは、乳房インプラント患者の診断サーベイランスを改善するための戦略的提携を発表しました。これは、Platinum20保証プログラムに裏打ちされた同社の安全性プロファイルの強化に役立つと期待されました。したがって、このような事例がCOVID-19以降の北米乳房再建市場を牽引すると予想されます。

北米乳房再建市場レポート・ハイライト

• 製品別では、インプラント部門が2022年に63.5%の最大市場シェアを占めました。しかし、組織拡張器セグメントは予測期間中、CAGR 6.9%と最も速い成長率で発展すると予測されています。これは、組織拡張器セグメント内の製品の進歩によるものです。
• 形状別では、円形セグメントが2022年に55.3％の最大シェアを占めました。しかし、解剖学的形状は、予測期間中にCAGR 6.9%の最も速い成長率を示すと予測されています。
• 最終用途に基づくと、病院セグメントが2022年中に55.3％のシェアで市場を独占すると予測されました。しかし、美容クリニックセグメントは予測期間中にCAGR 7.0%と最も高い成長率が予測されています。これは北米地域で美容師の数が増加しているためです。
• 地域に基づくと、米国は2022年に74.4％の最大の売上高シェアで市場を独占しました。これは、同国における乳がんおよび乳房再建手術件数の増加によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 北米の乳房再建市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 普及と成長の見通しマッピング
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因分析
• 北米乳房再建市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 北米乳房再建市場：製品推定・動向分析

• 北米の乳房再建市場：重要なポイント
• 北米乳房再建市場：製品動向と市場シェア分析、2022年および2030年
• インプラント
• 組織拡張器
• 無細胞真皮マトリックス

第5章 北米の乳房再建市場：形状推定・動向分析

• 北米の乳房再建市場：重要なポイント
• 北米の乳房再建市場：形状の動きと市場シェア分析、2022年と2030年
• 丸型
• 解剖学的形状

第6章 北米の乳房再建市場：最終用途の推定・動向分析

• 北米の乳房再建市場：重要なポイント
• 北米乳房再建市場：最終用途の動向と市場シェア分析、2022年と2030年
• 病院
• 美容クリニック
• 外来手術センター

第7章 北米の乳房再建市場：地域推定・動向分析

• 地域別の見通し
• 地域別の北米乳房再建市場：重要なポイント
• 北米
  • 市場推計・予測、2018～2030年
  • 米国
  • カナダ

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 市場参入企業の分類
  • Mentor Worldwide LLC
  • AbbVie Inc.
  • Integra LifeSciences
  • Sientra, Inc.
  • Stryker
  • Establishment Labs
  • RTI Surgical
  • MTF Biologics
  • Surgical Innovation Associates
  • TELA Bio, Inc.

List of Tables

• Table 1 List of Abbreviations
• Table 2 North America North America breast reconstruction market, by product, 2018 - 2030 (USD Million)
• Table 3 North America North America breast reconstruction market, by shape, 2018 - 2030 (USD Million)
• Table 4 North America North America breast reconstruction market, by end use, 2018 - 2030 (USD Million)
• Table 5 North America North America breast reconstruction market, by region, 2018 - 2030 (USD Million)
• Table 6 U.S. breast reconstruction market, by product, 2018 - 2030 (USD Million)
• Table 7 U.S. breast reconstruction market, by shape, 2018 - 2030 (USD Million)
• Table 8 U.S. breast reconstruction market, by end use, 2018 - 2030 (USD Million)
• Table 9 Canada breast reconstruction market, by product, 2018 - 2030 (USD Million)
• Table 10 Canada breast reconstruction market, by shape, 2018 - 2030 (USD Million)
• Table 11 Canada breast reconstruction market, by end use, 2018 - 2030 (USD Million)

List of Figure

Fig. 1 Market research process

Fig. 2 Data triangulation techniques

Fig. 3 Primary research pattern

Fig. 4 Market research approaches

Fig. 5 QFD modeling for market share assessment

Fig. 6 Market formulation & validation

Fig. 7 North America breast reconstruction: Market outlook

Fig. 8 North America breast reconstruction: Competitive insights

Fig. 9 Parent market outlook

Fig. 10 Related/ancillary market outlook

Fig. 11 Penetration and growth prospect mapping

Fig. 12 Industry value chain analysis

Fig. 13 North America breast reconstruction market driver impact

Fig. 14 North America breast reconstruction market restraint impact

Fig. 15 North America breast reconstruction market strategic initiatives analysis

Fig. 16 North America breast reconstruction market: Product movement analysis

Fig. 17 North America breast reconstruction market: Product outlook and key takeaways

Fig. 18 Implants market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 19 Silicone breast implants market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 20 Saline breast implants market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 21 Tissue expander market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 22 Saline expander market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 23 Air tissue expander market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 24 Acellular dermal matrix market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 25 North America breast reconstruction market: Shape movement analysis

Fig. 26 North America breast reconstruction market: Shape mode outlook and key takeaways

Fig. 27 Round shape market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 28 Anatomical shape market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 29 North America breast reconstruction market: End use movement analysis

Fig. 30 North America breast reconstruction market: End use outlook and key takeaways

Fig. 31 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 32 Cosmetology clinics market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 33 Ambulatory surgical centers market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 34 North America breast reconstruction market: Regional movement analysis

Fig. 35 North America breast reconstruction market: Regional outlook and key takeaways

Fig. 36 North America market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 37 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 38 Canada market estimates and forecasts, 2018 - 2030 (USD Million)

North America Breast Reconstruction Market Growth & Trends:

The North America breast reconstruction market size is expected to reach USD 366.2 million by 2030, registering a CAGR of 6.8% from 2023 to 2030, according to a new report by Grand View Research, Inc..This can be credited to the increase in number of breast cancer patients within this region. For instance, as per the Canadian Cancer Society 2019, one in eight females is expected to be diagnosed with breast cancer. Moreover, as per a similar source, breast cancer is the second most occurring cancer in Canada. Thus, the increasing number of breast cancer patients in Canada is predicted to boost the North America Breast Reconstruction market.

Moreover, the number of breast reconstruction surgery is also increasing in this region. For instance, as per the Archives of Plastic Surgery, post-mastectomy breast reconstruction surgery has increased from 19.4% in 2015 to 53.4% in 2018. Similarly, as per the Canadian Cancer Society, one in every five women in Canada goes under breast reconstruction post-mastectomy. Thus, a rise in the number of breast reconstruction surgery is anticipated to drive the North America breast reconstruction market.

Furthermore, the initiation of various awareness campaigns is leading to rising awareness among women. For instance, the Breast Reconstruction Awareness Campaign educates, engages & empowers females to take the right decision regarding breast reconstruction, post breast cancer diagnosis.

The North America breast reconstruction market witnessed a dip due to COVID-19. However, post-pandemic, the market is projected to have a significant growth rate. Elective surgeries such as breast augmentation, which were postponed during COVID-19, are expected to be held in the post-COVID-19 period. Moreover, to capture the market, many companies are entering into various strategies such as geographic expansion, product launches, and partnerships.

For instance, in April 2021, Sientra, Inc. and the Butterfly Network announced a strategic partnership to improve diagnostic surveillance of breast implant patients. This was expected to help the company to strengthen its safety profile, which was backed by the Platinum20 warranty program. Therefore, such instances are expected to drive the North America breast reconstruction market in the post-COVID-19 period.

North America Breast Reconstruction Market Report Highlights:

• In terms of product, the implants segment held the largest market share of 63.5% in 2022 in the market. However, the tissue expander segment is expected to develop with the fastest growth rate of 6.9% CAGR, during the forecast period. This can be credited to the advancement in the products within the tissue expander segment
• Based on shape, the round shape segment held the largest share of 55.3% in 2022 in the market. However, the anatomical shape is anticipated to witness the fastest growth rate of CAGR of 6.9% during the forecast period
• Based on end-use, the hospital segment was expected to dominate the market with a 55.3% share during 2022. However, the cosmetology clinics segment is projected to witness the highest growth rate of 7.0% CAGR during the forecast period. This can be credited to the rising number of cosmetologists in the North America region.
• Based on the region, the U.S. dominated the market with the largest revenue share of 74.4% in 2022. This can be credited to the increase in number of breast cancer & breast reconstruction procedures within this nation

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Shape
  • 1.1.3. End Use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Shape outlook
  • 2.2.3. End use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. North America Breast Reconstruction Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
  • 3.3.2. Market restraint analysis
• 3.4. North America Breast Reconstruction Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's Five Forces
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. North America Breast Reconstruction Market: Product Estimates & Trend Analysis

• 4.1. North America Breast Reconstruction Market: Key Takeaways
• 4.2. North America Breast Reconstruction Market: Product Movement & Market Share Analysis, 2022 & 2030
• 4.3. Implants
  • 4.3.1. Implants market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.3.2. Silicone breast implants
    • 4.3.2.1. Silicone breast implants estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.3.3. Saline breast implants
    • 4.3.3.1. Saline breast implants estimates and forecasts, 2018 to 2030 (USD Million)
• 4.4. Tissue Expander
  • 4.4.1. Tissue expander market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.2. Saline expander
    • 4.4.2.1. Saline expander estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.3. Air tissue expander
    • 4.4.3.1. Air tissue expander estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Acellular Dermal Matrix
  • 4.5.1. Acellular dermal matrix market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. North America Breast Reconstruction Market: Shape Estimates & Trend Analysis

• 5.1. North America Breast Reconstruction Market: Key Takeaways
• 5.2. North America Breast Reconstruction Market: Shape Movement & Market Share Analysis, 2022 & 2030
• 5.3. Round Shape
  • 5.3.1. Round shape market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.4. Anatomical Shape
  • 5.4.1. Anatomical shape market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. North America Breast Reconstruction Market: End Use Estimates & Trend Analysis

• 6.1. North America Breast Reconstruction Market: Key Takeaways
• 6.2. North America Breast Reconstruction Market: End-use Movement & Market Share Analysis, 2022 & 2030
• 6.3. Hospitals
  • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.4. Cosmetology Clinics
  • 6.4.1. Cosmetology clinics market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Ambulatory Surgical Centers
  • 6.5.1. Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. North America Breast Reconstruction Market: Regional Estimates & Trend Analysis

• 7.1. Regional Outlook
• 7.2. North America Breast Reconstruction Market by Region: Key Takeaways
• 7.3. North America
  • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Market Participant Categorization
  • 8.2.1. Mentor Worldwide LLC
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. AbbVie Inc.
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Integra LifeSciences
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Sientra, Inc.
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Stryker
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Establishment Labs
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. RTI Surgical
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. MTF Biologics
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Surgical Innovation Associates
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. TELA Bio, Inc.
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives